Hospital General de Agudos F. Santojanni, Buenos Aires (Argentina)
Follow
Contributor content
Presentation
Sotatercept as an alternative therapeutic strategy in high-risk pulmonary hypertension associated with systemic sclerosis and interstitial lung disease when prostacyclin therapy is not feasible
